Sandra Strauss is Professor of Medical and Teenage Young Adult (TYA) Oncology and a Consultant Medical Oncologist, specialising in the systemic treatment of bone and soft tissue sarcoma. She leads the clinical service at University College London Hospital, part of the London Sarcoma Service, one of the largest sarcoma services in Europe. Her academic post, based within University College London, is focused on translational and clinical research to develop novel therapies for sarcoma patients.
Sandra Strauss has over 15 years’ experience as a chief and principal investigator for international and national clinical trials. She chairs the executive committee of the EuroEwing consortium (EEC), a pan-European collaboration that has brought together clinicians, scientists and patient advocates to improve outcome for patients with Ewing sarcoma, conducting practice-changing clinical trials with focused translational research.
She is also an executive member of the Hibiscus Harmonization International Bone Sarcoma Consortium (HIBiSCus), a member of European Organisation for Research and Treatment of Cancer (EORTC) and Innovative Therapies for Children with Cancer (ITCC) consortium, as well as the Scientific committee of SIOPE, the European Society of paediatric oncology, and is the current sarcoma track chair of European Society of Medical Oncology (ESMO).
